Phase IIa study of αDC1 vaccines targeting HER2/HER3 combined with pembrolizumab in patients with asymptomatic brain metastasis from breast cancer.

Authors: Shipra Gandhi, Peter A. J. Forsyth, Mateusz Opyrchal, Audrey Rawleigh, Matthew Sydor, Kamran A. Ahmed, Kristopher Attwood, Patrick Michael Dillon, Camilo E. Fadul, Dheerendra Prasad, Sheheryar Kairas Kabraji, Ellis Glenn Levine, Kevin Kalinsky, Brian J. Czerniecki, Pawel Kalinski

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps2088

Source: Full article

---

Abstract

TPS2088